Legal Representation
Attorney
Maha Jafarey
USPTO Deadlines
Next Deadline
784 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220322)
Due Date
March 22, 2028
Grace Period Ends
September 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 22, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 4, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 4, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 15, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 1, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 1, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 1, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 1, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 1, 2021 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 1, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 1, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 1, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 1, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 3, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 3, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 3, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 29, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 29, 2020 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 28, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 1, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Investor development and management in the nature of business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Advisory board development and management being personnel management services; Regulatory compliance development and management in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
First Use Anywhere:
Mar 1, 2020
First Use in Commerce:
Mar 1, 2020
Class 042
Research and development in the pharmaceutical and biotechnology fields, Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and acute and chronic devastating diseases and conditions beyond cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
First Use Anywhere:
Mar 1, 2020
First Use in Commerce:
Mar 1, 2020
Additional Information
Design Mark
The mark consists of the stylized wording "3RDEYEBIO" with an incomplete, shaded letter "O" outlined with a single lined circle with four protruding diagonal lines from the circle and each connected to smaller shaded circles of varying sizes, forming a molecular model design. The background is for shading purposes only and is not claimed as a feature of the mark.
Pseudo Mark
THIRD EYE BIO
Classification
International Classes
035
042